Heart Failure Due to Systolic Dysfunction and Mortality in Diabetes: Pooled Analysis of 39,505 Subjects

Journal of Cardiac Failure

Volumn 15, Issue 4, 2009, Pages 305-309

  Kamalesh, Masoor ^a   Cleophas, Ton J ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b European College of Pharmaceutical Medicine   (France)

Author keywords

Diabetes; heart failure; mortality

Indexed keywords

ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DATA BASE; DEATH; DIABETES MELLITUS; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SURVIVAL; SYSTEMATIC REVIEW; SYSTOLIC DYSFUNCTION; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; HEART FAILURE, SYSTOLIC; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRENDS;

DIABETES MELLITUS, TYPE 2; HEART FAILURE; HEART FAILURE, SYSTOLIC; HOSPITALIZATION; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 65249170100     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.11.006     Document Type: Article

References (33)

1. Kamalesh M., and Nair G. Increasing prevalence of diabetes among patients with congestive heart failure. Int J Cardiol 104 (2005) 77-80
2. Adams Jr. K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
3. Kamalesh M. Heart failure in diabetes and related conditions. J Card Fail 13 (2007) 861-873
4. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections. Diabetes Care 21 (1998) 1414-1431
5. Oxman A.D., and Guyatt G.H. Guidelines for reading literature reviews. CMAJ 138 (1988) 697-703
6. Cleophas T.J., and Zwinderman A.H. Meta-analysis. Circulation 115 (2007) 2870-2875
7. Dries D.L., Sweitzer N.K., Drazner M.K., et al. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 38 (2001) 421-428
8. Bobbio M., Ferrua S., Opasich C., et al. Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers. J Card Failure 9 (2003) 192-202
9. Domanski M., Krause-Steinrauf H., Deedwania P., et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 42 (2003) 914-922
10. Gustaffson I., Brendorp B., Seibaek M., et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43 (2004) 771-777
11. De Groote P., Lamblin N., Mouquet F., et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 25 (2004) 656-662
12. Murcia A.M., Hennekens C.H., Lamas G.A., et al. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med 164 (2004) 2273-2279
13. Smooke S., Horwich T.B., and Fonarow G.C. Insulin-treated diabetes is associated with marked increase in mortality in patients with advanced heart failure. Am Heart J 149 (2005) 168-174
14. Gorelik O., Almoznino-Sarafian D., Alon I., et al. Heart failure in diabetes: clinical features and prognostic implications. Cardiology 103 (2005) 161-166
15. Burger A.J., Tsao L., and Aronson D. Prognostic impact of diabetes mellitus in patients with acute decompensated heart failure. Am J Cardiol 95 (2005) 1117-1119
16. Varela-Roman A., Grigorian S., Barge C.E., et al. Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. Eur J Heart Fail 7 (2005) 859-864
17. Deedwania P.C., Giles T.D., Klibaner M., Ghali J.K., Herlitz J., Hildebrandt P., et al. MERIT-HF Study Group. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. Am Heart J 149 (2005) 159-167
18. Kamalesh M., Subramanian U., Sawada S., Temkit M., Eckert G., and Tierney W. Diabetes and mortality due to congestive heart failure. Eur J Heart Fail 8 (2006) 404-408
19. From A.M., Leibson C.L., Bursi F., et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119 (2006) 591-599
20. Garcia C., Lupon J., Urrutia A., Gonzalez B., Herreros J., Altimir S., et al. Prognostic significance of diabetes in heart failure population: one year mortality and heart failure related hospital admission. Med Clin (Barc) 125 (2006) 161-165
21. Ahmed A., Aban I.B., Vaccarino V., Lloyd-Jones D.M., Goff D.C., Zhao J., et al. A propensity matched study of effect of diabetes on the natural history of heart failure: variations by sex and age. Heart 93 (2007) 1584-1590
22. Ghali J.K., Boehmer J., Feldman A.M., Saxon L.A., Demarco T., Carson P., et al. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. J Card Failure 13 (2007) 769-773
23. Tribouilloy C., Rusinaru D., Mahjoub H., Tartiere J.M., Kesri-Tartiere L., Godard S., et al. Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction. A prospective 5-year study. Heart (2008 Jan 20) [Epub ahead of print]
24. Nodari S., Metra M., Dei Cas A., and Dei Cas L. Efficacy and tolerability of the long term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus. Eur J Heart Fail 5 (2003) 803-809
25. Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, et al. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2007;154:277.e1-8. Erratum in: Am Heart J 2007;154:646.
26. American Heart Association Heart Disease and Stroke Update 2008. Heart disease and stroke statistics-2008 update (at-a-glance version). Available at: www.americanheart.org. Accessed March 10, 2008.
27. Roger V.L., Weston S.A., Redfield M.M., Hellermann-Homan J.P., Killian J., Yawn B.P., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292 (2004) 344-350
28. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
29. Levy D., Larson M.G., Vasan R.S., Kannel W.B., and Ho K.K. The progression from hypertension to congestive heart failure. JAMA 275 (1996) 1557-1562
30. Boudina S., and Abel D. Diabetic cardiomyopathy revisited. Circulation 115 (2007) 3213-3223
31. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
32. Nishio Y., Kashiwagi A., Kida Y., Kodama M., Abe N., Saeki Y., et al. Deficiency of cardiac beta-adrenergic receptor in streptozocin-induced diabetic rats. Diabetes 37 (1988) 1181-1187
33. Subramanian U, Kamalesh M, Temkit M. et al. Do cardioselective beta- blockers reduce mortality in diabetic subjects with congestive heart failure? Am J Cardiovasc Drugs. In press.